Ypsomed's ServoPen® for the treatment of Parkinson's disease
Austrian specialist pharmaceutical company, Ever Pharma, now offers the D-mine® Pen for the treatment of Parkinson patie…
Austrian specialist pharmaceutical company, Ever Pharma, now offers the D-mine® Pen for the treatment of Parkinson patie…
Ypsomed Group and the Chinese pharmaceutical company Tonghua Dongbao Pharmaceutical Co., Ltd. have further intensified t…
In business year 2014/15 Ypsomed Group posted consolidated sales of CHF 306.6 million, which represents an increase of 1…
Ypsomed has entered into an exclusive agreement to supply Indian pharmaceutical major Lupin Limited (Lupin) with its reu…
The Yposmed Group is well-positioned in the burgeoning Chinese diabetes market. With its newly founded subsidiary in Bei…
The Ypsomed Group, the leading developer and manufacturer of injection systems for self-medication and a diabetes specia…
In the first half of the 2014/15 financial year, the Ypsomed Group generated consolidated sales totaling CHF 148.5 milli…
Terumo Corporation a Japanese global operating medical technology group plans to supplement its range of products and se…
Burgdorf diabetes specialist Ypsomed can announce another success in the Injection Systems business segment: The British…
The issue of who is to succeed Simon Michel in Marketing & Sales has been resolved internally. The two business segments…